Hjem › Myeloproliferative neoplasmer › Kansas › Overland Park
Kliniske studier for Myeloproliferative neoplasmer i Overland Park, KS
3 studier for Myeloproliferative neoplasmer søker deltakere på steder i og rundt Overland Park (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi unna
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RekruttererFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi unna
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi unna
Myeloproliferative neoplasmer-studier i andre byer
- Houston, TX16 studier
- New York City, NY15 studier
- Boston, MA14 studier
- Milwaukee, WI10 studier
- Miami, FL10 studier
- Durham, NC9 studier
- Baldwin Park, CA9 studier
- Seattle, WA9 studier
- Chicago, IL9 studier
- Portland, OR8 studier
- Cleveland, OH8 studier
- Atlanta, GA8 studier
Andre studier i Overland Park
- Ikke-småcellet lungekreft16 studier
- Akut myelogen leukemi11 studier
- Lungekreft11 studier
- Brystkreft10 studier
- Atrieflimmer8 studier
- Kolorektal kreft8 studier
- Fedme7 studier
- Pankreaskreft7 studier
- Prostatakreft7 studier
- Melanom6 studier
- Overvekt6 studier
- Eggstokkreft6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.